相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer
Hari Singhal et al.
SCIENCE ADVANCES (2016)
Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial
Patricia A. Mote et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Progesterone action in breast, uterine, and ovarian cancers
Caroline H. Diep et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2015)
Progesterone receptor modulates ERα action in breast cancer
Hisham Mohammed et al.
NATURE (2015)
Ulipristal Acetate Inhibits Progesterone Receptor Isoform A-Mediated Human Breast Cancer Proliferation and BCl2-L1 Expression
Nathalie Esber et al.
PLOS ONE (2015)
Role of epigenetic modifications in luminal breast cancer
Hany A. Abdel-Hafiz et al.
EPIGENOMICS (2015)
Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters
Victoria Wargon et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Antiprogestins in gynecological diseases
Alicia A. Goyeneche et al.
REPRODUCTION (2015)
Progesterone receptor isoform A may regulate the effects of neoadjuvant aglepristone in canine mammary carcinoma
Silvia Guil-Luna et al.
BMC VETERINARY RESEARCH (2014)
Survivin family proteins as novel molecular determinants of doxorubicin resistance in organotypic human breast tumors
Alice Faversani et al.
BREAST CANCER RESEARCH (2014)
Neuroprotection by steroids after neurotrauma in organotypic spinal cord cultures: A key role for progesterone receptors and steroidal modulators of GABAA receptors
Florencia Labombarda et al.
NEUROPHARMACOLOGY (2013)
Antiprogestins in breast cancer treatment: are we ready?
Claudia Lanari et al.
ENDOCRINE-RELATED CANCER (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Differential Regulation of Breast Cancer-Associated Genes by Progesterone Receptor Isoforms PRA and PRB in a New Bi-Inducible Breast Cancer Cell Line
Junaid A. Khan et al.
PLOS ONE (2012)
Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas
Victoria Wargon et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Interaction between FGFR-2, STAT5, and Progesterone Receptors in Breast Cancer
Juan P. Cerliani et al.
CANCER RESEARCH (2011)
Progesterone Receptor Isoform-Specific Promoter Methylation: Association of PRA Promoter Methylation with Worse Outcome in Breast Cancer Patients
Thushangi N. Pathiraja et al.
CLINICAL CANCER RESEARCH (2011)
Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancer
W. Bu et al.
ONCOGENE (2011)
Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors
Valentina Vaira et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer
Christina Yau et al.
BREAST CANCER RESEARCH (2010)
Reversal of antiprogestin resistance and progesterone receptor isoform ratio in acquired resistant mammary carcinomas
Victoria Wargon et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer
Claudia Lanari et al.
ENDOCRINE-RELATED CANCER (2009)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Extracting binary signals from microarray time-course data
Debashis Sahoo et al.
NUCLEIC ACIDS RESEARCH (2007)
Differential expression and regulation of progesterone receptor isoforms in rat and mouse pituitary cells and LβT2 gonadotropes
Judith L. Turgeon et al.
JOURNAL OF ENDOCRINOLOGY (2006)
Progesterone receptor isoforms A and B: Temporal and spatial differences in expression during murine mammary gland development
MD Aupperlee et al.
ENDOCRINOLOGY (2005)
Breast cancer patients with progesterone receptor PR-A-rich tumors have poorer disease-free survival rates
TA Hopp et al.
CLINICAL CANCER RESEARCH (2004)
Antiandrogen effects of mifepristone on coactivator and corepressor interactions with the androgen receptor
LN Song et al.
MOLECULAR ENDOCRINOLOGY (2004)
Three novel hormone-responsive cell lines derived from primary human breast carcinomas:: Functional characterization
SM Vázquez et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform
B Mulac-Jericevic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Breast cancer and hormone-replacement therapy in the Million Women Study
E Banks et al.
LANCET (2003)
Progesterone receptors A and B differentially affect the growth of estrogen-dependent human breast tumor xenografts
CA Sartorius et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Progesterone receptor expression in medroxyprogesterone acetate-induced murine mammary carcinomas and response to endocrine treatment
LA Helguero et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
p21, p27 and p53 in estrogen and antiprogestin-induced tumor regression of experimental mouse mammary ductal carcinomas
S Vanzulli et al.
CARCINOGENESIS (2002)
Detection of progesterone receptor forms A and B by immunohistochemical analysis
PA Mote et al.
JOURNAL OF CLINICAL PATHOLOGY (2001)
Progesterone receptor A and B isoforms in the human breast and its disorders
N Ariga et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2001)
Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancer
JGM Klijn et al.
STEROIDS (2000)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
分享论文
